Search results
An Intrinsic Calculation For Strathcona Resources Ltd. (TSE:SCR) Suggests It's 22% Undervalued
Simply Wall St. via Yahoo Finance· 2 weeks agoKey Insights Strathcona Resources' estimated fair value is CA$40.20 based on 2 Stage Free Cash Flow...
Silver Crown Royalties (SCR) to Receive 90% of Silver Output From Pilar Gold's PGDM Complex
NewMediaWire via Yahoo Finance· 7 months agoVANCOUVER, BC - (NewMediaWire) - October 26, 2023 - TheNewswire Global Stocks News Silver Crown...
A Note On Strathcona Resources Ltd.'s (TSE:SCR) ROE and Debt To Equity
Simply Wall St. via Yahoo Finance· 2 months agoMany investors are still learning about the various metrics that can be useful when analysing a...
Unload These 3 EV Stock Nightmares to Swerve Steeper Losses
InvestorPlace via Yahoo Finance· 3 weeks agoThe road to full electrification still has a long way to go. The EV market has struggled since last...
3 Top Dividend Stocks On Euronext Paris With Yields Up To 9.2%
Simply Wall St. via Yahoo Finance· 1 day agoAmidst a backdrop of cautious optimism in the European markets, where recent ECB comments have...
Zacks Industry Outlook Highlights Donaldson, Atmus Filtration Technologies and Fuel Tech
Zacks via Yahoo Finance· 2 months agoFor Immediate Release Chicago, IL – April 5, 2024 – Today, Zacks Equity Research discusses Donaldson...
FDA Lifts Clinical Hold On BioCryst's BCX9930 Program For Rare Blood Disorder
Benzinga via Yahoo Finance· 2 years agoThe FDA lifted a partial clinical hold on BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) BCX9930...
Exploring Top Dividend Stocks In France For March 2024
Simply Wall St. via Yahoo Finance· 2 months agoAmidst a backdrop of fluctuating global markets, with the Federal Reserve holding interest rates...
Scandal Effect - Toyota-Led Commercial Vehicle Partnership Expels Hino Motors
Benzinga via Yahoo Finance· 2 years agoCommercial Japan Partnership Technologies Corporation (CJPT), of which Toyota Motor Corp (NYSE: TM)...
Why Immix Biopharma Shares Are Surging Today?
Benzinga via Yahoo Finance· 1 year agoImmix Biopharma Inc (NASDAQ: IMMX) announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 (formerly HBI0101). In an ongoing...